Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

FARAFARA Cure FA

 

News & Press Releases

Here you will find the most recent organizational news from FARA, including information on events, and awareness and advocacy initiatives. To locate an article from a certain date, please use the archives on the right side of your screen.

 

Raytheon Support Group Helps Match Service Dog Shadow with 9-Year-Old Donovan

As many WebRing readers know, WebRing has been following the story of Raytheon Persons with DisAbilities (RPDA) member and Raytheon Parents of Dependents with Special Needs (RPODS) chairwoman Mary-Lisa Orth. Orth’s twin sons, Benjamin and Alexander, were diagnosed with Friedreich’s Ataxia disease in 1999 (see WebRing Volume 2, Issue 3, page 3). In 2004, Benjamin died from complications of scoliosis surgery. After Benjamin’s tragic death, his brother Alexander no longer had an interest in completing the training for Benjamin’s service dog Shadow. Last April, Orth took Shadow to a family in Yonkers, New York, that she met in Boston at the annual National Friedreich’s Ataxia Conference in March. Orth had corresponded with the family for two years through the Friedreich’s Ataxia parents’ group list serve. The family includes a 9-year-old boy, Donovan, who also has Friedreich’s Ataxia.

Read More: Raytheon Support Group Helps Match Service Dog Shadow with 9-Year-Old Donovan

Friedrich's Ataxia Patient Raising Funds for Research

Friedrich's ataxia--or FA for short--is a disease that affects one in 50,000 people. It attacks the central nervous system. There's no treatment, and no cure.

But one Savannah woman is hoping to change that. Lindsay Ashman, 26, isn't giving up without a fight. Even though her body is failing her, she's racing against the clock to find a cure.

Being in a wheelchair doesn't slow Ashman down. In fact, it helps her go faster as she tries to keep up with her 4-year-old son, Clay.

Her biggest challenge is maneuvering her power wheelchair, but even that doesn't stop her from doing everyday tasks like picking up after her son. "It's become so normal, I don't even notice it anymore," she said.

Ashman is slowly losing all control of her muscles due to FA. She was diagnosed 2 1/2 years ago and the disease has slowly worsened. Her speech is slightly slurred, and she's lost most of her ability to move.

Read More: Friedrich's Ataxia Patient Raising Funds for Research

Friedreich's Ataxia Research Alliance Announces Support from NIH RAID Pilot Program

Washington, D.C. — The Friedreich's Ataxia Research Alliance announced today that the National Institutes of Health has accepted the University of Pennsylvania and Edison Pharmaceuticals into the Rapid Access to Interventional Development (RAID) Pilot Program for the development of Edison Pharmaceuticals EPI-A0001 for Friedreich's ataxia.

Under the NIH Roadmap initiative, the RAID Pilot Program has assembled an inter-institute team consisting of the National Institute of Neurological Disorders and Stroke, the National Institute of Child Health and Human Development and the Developmental Therapeutics Program of the National Cancer Institute that will combine resources and expertise to translate EPI-A0001 into the clinic. This NIH RAID project will provide drug development guidance and resources to enable an Investigative New Drug application to be filed with the Food and Drug Administration- the first step in its regulatory submission process. The Orphan Products Division of the Food and Drug Administration recently awarded EPI-A0001, Orphan Designation status for inherited respiratory chain diseases of the mitochondria.

Read more: Friedreich's Ataxia Research Alliance Announces Support from NIH RAID Pilot Program

MDA and FARA to Accelerate Friedreich's Ataxia Research

Tucson, Arizona — The Muscular Dystrophy Association (MDA) and the Friedreich's Ataxia Research Alliance (FARA) announced today that they will accelerate their joint efforts to combat Friedreich's ataxia, a devastating neuromuscular disorder affecting both children and adults.

Leaders of the organizations met at the MDA national headquarters in Tucson to agree on the most expeditious means for enhancing and advancing their partnership. The discussion centered on a number of leading therapeutic approaches that are expected to be in clinical trials within the next year and that hold great promise for the development of a therapy for Friedreich's ataxia. The two organizations agreed that these clinical projects show a real prospect for effective treatment and that, with a fully enhanced partnership, the MDA and FARA will achieve that goal much sooner.

Read more: MDA and FARA to Accelerate Friedreich's Ataxia Research

EDS and RIT Partner to Develop Solution for Friedreich's Ataxia Research

When the Friedreich's Ataxia Research Alliance (FARA) recognized the value of having a patient registry process and data repository to collect patient information globally, they called their friends at EDS for a technical solution. FARA knew that having this information at its fingertips would give them the ability to identify candidates for clinical studies within a short timeframe as well as enable outreach activities through education materials and newsletters.

After gathering FARA's high level requirements, a team of EDS volunteers from Rochester, N.Y., turned to their local education partner - Rochester Institute of Technology (RIT) - to see if the project would be a fit for RIT's B. Thomas Golisano College of Computing and Information Sciences' Software Engineering Department's senior capstone project.

RIT's undergraduate software engineering curriculum calls for students to work as a team, much like they would in a real job environment. The senior capstone project is completed over a 20-week period. The educational value is further enhanced with the curriculum requirement that students complete the project for a real client.

Read more: EDS and RIT Partner to Develop Solution for Friedreich's Ataxia Research
Page 80 of 83

SHARE

FacebookTwitterLinkedInYoutube
Event H.jpg

News & Press Archives